经尿道前列腺剜切术与电切术治疗高危前列腺增生症的临床疗效观察

Transurethral enucleation and resection versus transurethral resection of the prostate in the treatment of high-risk benign prostatic hyperplasia

目的:探讨等离子经尿道前列腺剜切术(TUERP)与经尿道前列腺电切术(TURP)治疗高危良性前列腺增生(HBPH)的临床疗效。方法:选取我院于2018年6~12月收治的HBPH患者60例,并按照随机分配原则分为两组,试验组和对照组各30例,对照组患者行TURP治疗,试验组患者行TUERP治疗,记录并比较两组患者的手术时间、手术失血量、术后并发症及切除的前列腺体积等临床指标。结果:试验组患者的手术时间[(47.5±16.1) min vs(76.2±15.9) min]、手术失血量[(60.5±25.4) ml vs(93.7±33.6) ml]均显著低于对照组(P<0.05),而切除的前列腺体积显著大于对照组[(42.3±12.2) g vs(30.6±8.5) g](P<0.05),术后并发症如出血、尿失禁、尿道狭窄等例数均少于对照组。结论:TUERP与TURP治疗HBPH均具有较好临床效果,但TUERP的手术失血量较少,手术时间短,术后并发症少,切除的前列腺体积更大,手术创伤更小,更适合用于治疗HBPH。

Objective: To investigate the clinical effect of transurethral enucleation and resection of the prostate(TUERP) versus that of transurethral resection of the prostate(TURP) in the treatment of high-risk BPH. Methods: From June 2018 to December 2018, a total of 60 patients with high-risk BPH were randomly assigned to receive TUERP(n = 30) or TURP(n = 30). Comparisons were made between the two groups of patients in the operation time, intraoperative blood loss, volume of the resected prostate, and postoperative complications. Results: Compared with the patients treated by TURP, those in the TUERP group showed a significantly shorter operation time([76.2±15.9] min vs [47.5±16.1] min, P < 0.05), less intraoperative blood loss([93.7±33.6 vs [60.5±25.4] ml] ml, P < 0.05), but a larger volume of the resected prostate([30.6±8.5] g vs [42.3±12.2] g, P < 0.05), and a less incidence of postoperative complications, such as secondary bleeding, uracratia and urethrostenosis. Conclusion: Both TUERP and TURP are clinically effective for the treatment of high-risk BPH, but TUERP is even better than TURP for its advantages of shorter operation time, less intraoperative blood loss, larger volume of resected prostate, fewer postoperative complications, and less surgical trauma.